Mitral Regurgitation
213
50
62
66
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
23 trials with published results (11%)
Research Maturity
66 completed trials (31% of total)
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
5.2%
11 terminated out of 213 trials
85.7%
-0.8% vs benchmark
4%
8 trials in Phase 3/4
35%
23 of 66 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 66 completed trials
Clinical Trials (213)
Implantation of a Permanent Interatrial Shunt to Reduce Left Atrial Filling Pressures Following MitraClip
ATLAS (AltaValve) Pivotal Trial
Mixed Reality in MitraClip Implantation: Preliminary Case Series
Exploratory Study of the Diagnostic Potential of an Innovative Thoracic Vibration Analysis Technique
The REValve Clinical Trial an Evaluation Of the ReValve Palmetto Valve for the Replacement of the Native Mitral VaLVE
Clinical Trial to Evaluate the Safety and Effectiveness of Using the Tendyne Transcatheter Mitral Valve System for the Treatment of Symptomatic Mitral Regurgitation
SAPIEN M3 EFS: Early Feasibility Study of the Edwards SAPIEN M3 System for the Treatment of Mitral Regurgitation
Capstan Medical TMVR Study: FIH
Cephea Early Feasibility Study
Edwards PASCAL CLASP IID/IIF Pivotal Clinical Trial
Transcatheter Mitral Valve Replacement in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO-EU Trial
The CardioClip Study
Anchord Mitral Chordal Repair System - FIH
Cardiovalve Transfemoral Mitral Valve System
Abbott Cephea Mitral Valve Disease Registry
The Role of cardIac magNeTic rEsonance in surGical Decision Making in Patients With Severe pRimAry miTral rEgurgitation
Artificial Intelligence Assisting Transcatheter Mitral Edge-to-Edge Repair
Evaluation of a Management Algorithm for TAVI Patients With Concomitant Mitral or Tricuspid Regurgitation
Reduction of Elimination of Mitral Regurgitation With the SATURN TMVR System (CASSINI-US)
Active Post-Market Surveillance of Innovative Devices for Valvular Heart Disease